Biotech

All Articles

ArsenalBio raises $325M, pivots away from past lead asset

.Collection Biosciences is actually carrying on up. The cell treatment provider has added on $325 th...

Lilly- backed effective weight loss biotech reports IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana usage medication flunks period 2b, steering Indivior to review $100M option

.Aelis Farma's chances of getting a simple, favorable choice on a $100 thousand choice settlement ha...

ProKidney standstills period 3 test certainly not required for tissue therapy permission

.ProKidney has actually stopped one of a pair of phase 3 tests for its tissue treatment for kidney d...

Vaxcyte climbs on 'spectacular' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what analysts called "remarkable" stage 1/2 data for its own 31-valent pneumococca...

Recursion's human brain disease test reveals scant evidence of efficiency

.Recursion has actually discovered through a very early examination of its tech-enabled method to me...

Acepodia, Pfizer click together for chemistry-based cell therapy

.Phone it an instance of good chemical make up: Acepodia, a biotech based upon Nobel Prize-winning s...

Praxis epilepsy medicine lessens confiscations in stage 2 hearing

.Praxis Accuracy Medicines has racked up an additional midphase succeed in epilepsy this year, with ...

Three execs surrender as Dyne articles combined data for DMD candidate

.After running away a medical hold a number of years back, Dyne Therapy has shown brand-new stage 1/...

Arrowhead fires off period 3 information in uncommon metabolic condition ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its own give in advance of a potential face-off al...